Wegovy
Product
by Novo Nordisk
Wegovy is a brand name for semaglutide, an anti-obesity medication developed by Novo Nordisk for chronic weight management. Administered as a weekly subcutaneous injection, it acts as a GLP-1 receptor agonist to regulate appetite and food intake.
2 episodes featuring Wegovy
Modern Wisdom
Dr. K links compulsive habits to a crisis of meaning
The conversation argues that pornography, gambling, gaming and digital substitutes become most dangerous when they replace relationships, purpose and real-world progress.
Sep 17, 2026 · 3h 4m
This Week in Startups
Dr Mark Hyman outlines how data-driven testing is reforming patient care
As chronic illness rises, shifting from reactive symptom management to proactive, data-driven health tracking could dramatically extend human healthspan.
Sep 4, 2026 · 58 min